NVNO · enVVeno Medical Corporation Common Stock
View on chartInsiders & Stakes
| Robert Andrew Berman CEO | ▲ Buy | Open Market | 222,236 Shares held | 12/19/2024 | View profile |
| Glickman Marc H. SVP & Chief Medical Officer | ▲ Buy | Grant | 101,600 Shares held | 11/30/2021 | View profile |
| Glynn Craig Chief Financial Officer | ▲ Buy | Grant | 50,000 Shares held | 11/30/2021 | View profile |
| Matthew Jenusaitis Director | ▲ Buy | Open Market | 16,545 Shares held | 12/19/2024 | View profile |
| Robert Gray Director | ▲ Buy | Open Market | 11,155 Shares held | 12/31/2024 | View profile |
| Sanjay Shrivastava Director | ▲ Buy | Open Market | 9,288 Shares held | 12/24/2024 | View profile |
| Francis Duhay Director | ▼ Sell | Open Market | 2,351 Shares held | 9/11/2026 | View profile |
| Hamed Alavi Chief Technology Officer | ▼ Sell | Open Market | 0 Shares held | 3/13/2024 | View profile |
Transaction History
| Francis Duhay | ▼ Sell | Open Market | 11 | $123 | 9/11/2026 |
| Francis Duhay | ▼ Sell | Open Market | 140 | $1K | 6/11/2026 |
| Francis Duhay | ▼ Sell | Open Market | 140 | $2K | 3/12/2026 |
| Francis Duhay | ▼ Sell | Open Market | 4,900 | $2K | 12/11/2025 |
| Francis Duhay | ▼ Sell | Open Market | 4,900 | $4K | 9/15/2025 |
| Francis Duhay | ▲ Buy | Open Market | 81,433 | $250K | 12/31/2024 |
| Robert Gray | ▲ Buy | Open Market | 3,500 | $10K | 12/31/2024 |
| Sanjay Shrivastava | ▲ Buy | Open Market | 5,400 | $16K | 12/24/2024 |
| Matthew Jenusaitis | ▲ Buy | Open Market | 9,620 | $24K | 12/19/2024 |
| Robert Andrew Berman | ▲ Buy | Open Market | 12,000 | $31K | 12/19/2024 |
| Hamed Alavi | ▲ Buy | Option Exercise | 8,334 | $30K | 3/13/2024 |
| Hamed Alavi | ▼ Sell | Open Market | 8,334 | $52K | 3/13/2024 |
| Robert Gray | ▲ Buy | Option Exercise | 1,041 | — | 9/13/2022 |
| Matthew Jenusaitis | ▲ Buy | Option Exercise | 1,041 | — | 9/13/2022 |
| Francis Duhay | ▲ Buy | Open Market | 7,751 | $48K | 8/16/2022 |
| Sanjay Shrivastava | ▲ Buy | Open Market | 1,000 | $4K | 6/30/2022 |
| Robert Andrew Berman | ▲ Buy | Open Market | 2,500 | $10K | 6/27/2022 |
| Glickman Marc H. | ▲ Buy | Grant | 100,000 | — | 11/30/2021 |
| Robert Andrew Berman | ▲ Buy | Grant | 200,000 | — | 11/30/2021 |
| Glynn Craig | ▲ Buy | Grant | 50,000 | — | 11/30/2021 |
| Robert Andrew Berman | ▲ Buy | Open Market | 2,000 | $15K | 11/19/2021 |
| Sanjay Shrivastava | ▲ Buy | Option Exercise | 388 | — | 11/16/2021 |
| Robert Andrew Berman | ▲ Buy | Open Market | 2,000 | $16K | 11/16/2021 |
| Matthew Jenusaitis | ▲ Buy | Option Exercise | 1,042 | — | 9/13/2021 |
| Robert Gray | ▲ Buy | Option Exercise | 1,042 | — | 9/13/2021 |
| Matthew Jenusaitis | ▲ Buy | Open Market | 1,300 | $10K | 8/25/2021 |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 3, 2026
enVVeno Medical to Showcase enVVe System at VEINS 2026 Summit
enVVeno Medical Corporation announced that its first-in-class enVVe system will be featured at The VEINS 2026 Innovation Summit. This event highlights the company's progress as it moves toward a U.S. pivotal trial for its medical technology. The announcement serves as a key milestone in the development timeline for the device.
enVVeno Medical to Showcase enVVe System at VEINS 2026 Summit. enVVeno Medical Corporation announced that its first-in-class enVVe system will be featured at The VEINS 2026 Innovation Summit. This event highlights the company's progress as it moves toward a U.S. pivotal trial for its medical technology. The announcement serves as a key milestone in the development timeline for the device.